Caroline Man Xu has extensive experience leading global and regional cross-functional teams including 10 years at Novartis where she had global responsibilities for new products in the neuroscience, ophthalmology, and oncology fields. Prior to Novartis, she was senior management consultant at McKinsey & Company where she focused on Pharma/Biotech strategy, R&D, M&A, marketing, and operations. Caroline trained as a pharmacologist with over five years scientific drug research at the Medical Center of Columbia University in New York, Technical University Munich (TUM) and Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS).
Caroline has a Ph.D. in Molecular Pharmacology from TUM Munich and an MBA from Cornell University.